Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter
about
Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depressionRelease of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transportersGenetic update on inflammatory factors in ulcerative colitis: Review of the current literatureStrategies of bacterial over expression of membrane transporters relevant in human health: the successful case of the three members of OCTN subfamilyTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?Renal drug transporters and their significance in drug-drug interactionsFunctional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiencyDevelopment and characterization of an animal model of carnitine deficiencyFunctional variants of OCTN cation transporter genes are associated with Crohn diseaseAbsorbing competition for carnitineNa+- and Cl--coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytesCaveolin-1--a novel interacting partner of organic cation/carnitine transporter (Octn2): effect of protein kinase C on this interaction in rat astrocytesMembrane transporters as mediators of Cisplatin effects and side effects.Pharmacogenomics of diuretic drugs: data on rare monogenic disorders and on polymorphisms and requirements for further research.Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity.Role of plasma membrane transporters in muscle metabolism.Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasisCarnitine biosynthesis in mammals.Glycosylation of the OCTN2 carnitine transporter: study of natural mutations identified in patients with primary carnitine deficiencyThe organic cation transporter OCT2 mediates the uptake of beta-adrenoceptor antagonists across the apical membrane of renal LLC-PK(1) cell monolayers.Reduced L-carnitine transport in aortic endothelial cells from spontaneously hypertensive ratsFour cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers.Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 ProteinsMolecular and cellular physiology of renal organic cation and anion transport.A substrate pharmacophore for the human organic cation/carnitine transporter identifies compounds associated with rhabdomyolysis.Low-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cellsAcetyl-L-carnitine increases mitochondrial protein acetylation in the aged rat heart.Contributions of phosphorylation to regulation of OCTN2 uptake of carnitine are minimal in BeWo cells.Cisplatin-induced downregulation of OCTN2 affects carnitine wastingTransport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+)The epithelial cholinergic system of the airways.The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family.Transport of L-carnitine in human corneal and conjunctival epithelial cells.Cellular Metabolism and Dose Reveal Carnitine-Dependent and -Independent Mechanisms of Butyrate Oxidation in Colorectal Cancer Cells.Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat.Carnitine transport and fatty acid oxidation.A synthetic luciferin improves in vivo bioluminescence imaging of gene expression in cardiovascular brain regionsIdentification of mutations and evaluation of cardiomyopathy in Turkish patients with primary carnitine deficiency.
P2860
Q24611123-7E6C7599-A5D8-4E62-9F68-27EFA7A4882EQ24673439-4660EBF1-0020-41BE-B7B6-00DD2CF01A4CQ26852514-46D02AA0-5BAD-45A7-8241-2A43177FE023Q27010565-F8FBEC04-025A-417A-A3D8-96440CC5D9B1Q27690256-50630523-9BC8-4201-A538-5483BCF7433AQ28071292-5A21BE12-DB74-4066-BD30-C1645552F17DQ28204696-34341694-682E-45C7-9960-3DFCDEE42C6AQ28204749-DDA5A67B-2222-466C-8A3C-7E29D8254B92Q28258410-2B0F8D82-D4DE-4E5C-BBBA-0C672B7B16C1Q28362815-8B37B972-CCB5-4593-AA0B-36E0B99FF671Q28362820-74A0BF06-CF6C-4D66-BC9E-7B8E9A0CE890Q28537671-13AFF977-EE46-44EE-A939-7E92B5D0CE40Q30446860-423D46EE-D7D2-455B-A8AE-E71C81EDD93EQ30883430-B5A6A2AD-5D09-4180-9EE3-9A83228FA7DFQ33714593-5FED413C-DFE2-444E-B290-99F2E06D7E01Q33828918-A1AEEC74-9A43-4664-8442-AA34164885BAQ33973728-A96941B5-31F0-4113-869E-1747D5732215Q33985125-583DE502-4E39-4901-8A8A-3BB0DC9C1A00Q34094462-29A8679F-905B-4066-9818-7FED4E29D47AQ34501779-45F33128-F150-407F-83B3-69FD230486C4Q34516657-F859A393-69D6-47E1-9D56-963A65D8171FQ35042643-84D38D0F-CE99-4356-8176-D47FF42405DFQ35108977-BACD8B66-24C7-437C-8734-67EB65AD8C82Q35156413-C0FCBC8A-D044-4CB0-98BD-EE20F4B01639Q35795744-F36E57B8-D537-42AA-8D28-C315B6748DA8Q35842999-54102CE0-745A-4304-919A-8F1E3AD9747AQ35869583-1D12BCE3-D4AA-40DA-A739-2568873CF8BAQ35928472-A06E792B-76EB-4B0F-8188-521F3D414A2EQ36461206-EC0D2889-8240-4D82-96D5-A0270D433CA8Q36478844-2AD4C407-148E-41C2-8B7E-0A1D0092BA38Q36491674-755E1DD0-C6DC-4DFD-8B68-C87673C6A9DAQ36640736-2CA73651-44F5-4343-ACE9-81F06083DDB5Q37195830-3F6E133C-D9AB-4745-A33E-852D498887E3Q38962943-0DB79D68-9664-411C-88DA-F60EB5BC8932Q39636436-A1821FD9-131A-47B9-A3CB-6D083020E25AQ40217728-01101D3B-9FFC-4EAD-9AEB-6E00B2CBA957Q40950605-7D87D7CD-7DF3-4F65-BEF3-366AE47D7524Q41633875-45A3BADC-4361-4161-BF24-BE9E08749ED4Q41656097-338E394C-9F09-483E-8C4A-F3DF30BDD168Q41779087-D03331F9-3A69-49C6-8FD0-2E5CBB4BCD11
P2860
Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Functional characteristics and ...... c cation/carnitine transporter
@ast
Functional characteristics and ...... c cation/carnitine transporter
@en
Functional characteristics and ...... c cation/carnitine transporter
@nl
type
label
Functional characteristics and ...... c cation/carnitine transporter
@ast
Functional characteristics and ...... c cation/carnitine transporter
@en
Functional characteristics and ...... c cation/carnitine transporter
@nl
prefLabel
Functional characteristics and ...... c cation/carnitine transporter
@ast
Functional characteristics and ...... c cation/carnitine transporter
@en
Functional characteristics and ...... c cation/carnitine transporter
@nl
P2093
P2860
P3181
P356
P1476
Functional characteristics and ...... c cation/carnitine transporter
@en
P2093
F H Leibach
P D Prasad
V Ganapathy
P2860
P304
P3181
P356
10.1074/JBC.274.47.33388
P407
P50
P577
1999-09-01T00:00:00Z